Erika Carmel-Tech Ltd (TLV:ERKA)

Market Cap	23.23M -18.0%
Revenue (ttm)	39.63M +20.5%
Net Income	-11.45M
EPS	-0.11
Shares Out	104.17M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,000
Average Volume	46,830
Open	22.30
Previous Close	22.30
Day's Range	21.70 - 22.60
52-Week Range	15.00 - 31.00
Beta	1.54
RSI	45.89
Earnings Date	Apr 28, 2026

About Erika Carmel-Tech

Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. The company treats achilles tendon inflammation, burns, carpal tunnel syndrome, finger joint pain, fibromyalgia, hip pain, post-dental treatment, lower ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 44
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: ERKA

Financial Performance

In 2024, Erika Carmel-Tech's revenue was 37.96 million, an increase of 27.03% compared to the previous year's 29.88 million. Losses were -9.47 million, -50.73% less than in 2023.